Challenge: Led by Ernst & Young, the government, science sector, industrial sector and stock exchange want to improve the reputation of the biotech and medtech sectors among international investors.
Solution: The “Swiss Biotech Report” and the “Swiss Medtech Report” are two informative publications with a journalistic approach. Company portraits; reports from the worlds of research, science and finance; and information on the advantages of locating a business in Switzerland offer an excellent picture of Switzerland’s competitiveness in both sectors.
Result: The reports were met with a great deal of interest and sold like hot cakes, and the launch received a great deal of press coverage. The reports have been cited in the Financial Times Deutschland, on Bloomberg, on 10vor10 and on the Tagesschau, among others.
Ernst & Young